A carregar...
Long-Term Effect of Antibodies against Infused Alpha-Galactosidase A in Fabry Disease on Plasma and Urinary (lyso)Gb3 Reduction and Treatment Outcome
INTRODUCTION: Enzyme replacement therapy (ERT) with alpha-Galactosidase A (aGal A) may cause antibody (AB) formation against aGal A in males with Fabry disease (FD). Anti agalsidase ABs negatively influence globotriaosylceramide (Gb3) reduction. We investigated the impact of agalsidase AB on Gb3 and...
Na minha lista:
Main Authors: | , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Public Library of Science
2012
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3477102/ https://ncbi.nlm.nih.gov/pubmed/23094092 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0047805 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|